Insider Transactions in Q3 2023 at Magenta Therapeutics, Inc. (MGTA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
24,670
+1.26%
|
$320,710
$13.63 P/Share
|
|
Sep 26
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+1.55%
|
$390,000
$13.15 P/Share
|
|
Sep 22
2023
|
Simrat Randhawa CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+33.33%
|
$26,000
$13.2 P/Share
|
|
Sep 21
2023
|
Simrat Randhawa CHIEF MEDICAL OFFICER |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$26,000
$13.2 P/Share
|
|
Sep 19
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
30,000
+1.58%
|
$390,000
$13.2 P/Share
|
|
Sep 13
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
9,367
+0.51%
|
$103,037
$11.76 P/Share
|
|
Sep 12
2023
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
14,887
+0.81%
|
$148,870
$10.85 P/Share
|